Stay updated with breaking news from Protein Engineering Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parkinson's disease (PD) is a common neurodegenerative disorder caused by the death of dopaminergic neurons in a part of the brain (known as substantia nigra pars compacta), which leads to a deficit of dopamine (DA), one of the main neurotransmitters active in the central nervous system.
Polymeric Nanoparticles Deliver Dopamine to Parkinson’s-Affected Rat Brain Written by AZoNanoJun 2 2021 Parkinson’s disease (PD) is a general neurodegenerative disorder that occurs due to the death of dopaminergic neurons in a part of the brain (called substantia nigra pars compacta), which results in a lack of dopamine (DA), one of the principal neurotransmitters active in the central nervous system. Nanoencapsulation of dopamine. Image Credit: ICN2/IBB-UAB. The focus of symptomatic treatment for PD is to increase the concentration of dopamine in the brain. But dopamine is not administer...
Credit: ICN2/IBB-UAB Parkinson's disease (PD) is a common neurodegenerative disorder caused by the death of dopaminergic neurons in a part of the brain (known as substantia nigra pars compacta), which leads to a deficit of dopamine (DA), one of the main neurotransmitters active in the central nervous system. Symptomatic treatment focuses on increasing the concentration of dopamine into the brain. However, dopamine is not directly administered, because it is unable to cross the so called blood-brain barrier, which prevents some of the substances circulating in the blood to penetrate into the n...